BM
BioMark Diagnostics Inc.
BMKDF · OTC
$0.41 +0.00% (+$0.00)
1M +19.14%
Market Cap $60.8M
P/E Ratio -
Div. Yield -
ROE 250.76%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 2,185.82x
P/B 106.37x
P/E N/A
Growth
100 /100
Growing Rev. growth 51.98%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 406.91%
Net margin 5,127.10%
FCF margin 3,832.08%
Quality
0 /100
Poor ROIC 69.63%
ROE 250.76%
Asset turnover 0.01x
Debt
13 /100
High Debt/Equity 2.64x
Current ratio 1.29x
Int. coverage -21.31x
Stability
37 /100
Moderate Beta -0.31x
Rev. volatility 143.86%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BMKDF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rashid Ahmed Maula Bux
Employees
9
Headquarters
Richmond